Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data.

Literature DB >> 23192955

The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data.

Abstract

Results from different types of clinical research studies provide different types of evidence for evaluating the effects of a new drug or intervention. For this reason, it is important to recognize this phenomenon during reporting and to choose appropriate language to match the type of study that was done, because this can become critical to the interpretation and application of the results in clinical practice. In this article, we aim to highlight this issue through a series of examples and provide some guidance on what the appropriate language for different types of studies should be.

Mesh：

Year: 2012 PMID： 23192955 PMCID： PMC6652614 DOI： 10.1002/clc.22066

Source DB: PubMed Journal: Clin Cardiol ISSN： 0160-9289 Impact factor: 2.882

18 in total

1. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal: BMJ Date: 2010-03-23

2. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors: Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal: N Engl J Med Date: 2007-02-12 Impact factor: 91.245

3. Statins and the risk of colorectal cancer.

Authors: Jenny N Poynter; Stephen B Gruber; Peter D R Higgins; Ronit Almog; Joseph D Bonner; Hedy S Rennert; Marcelo Low; Joel K Greenson; Gad Rennert
Journal: N Engl J Med Date: 2005-05-26 Impact factor: 91.245

4. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors: Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal: JAMA Date: 2004-04-14 Impact factor: 56.272

5. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors: Kenneth F Schulz; Douglas G Altman; David Moher
Journal: BMJ Date: 2010-03-23

6. Long-term follow-up of the West of Scotland Coronary Prevention Study.

Authors: Ian Ford; Heather Murray; Chris J Packard; James Shepherd; Peter W Macfarlane; Stuart M Cobbe
Journal: N Engl J Med Date: 2007-10-11 Impact factor: 91.245

7. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.

Authors: Emilio Di Lorenzo; Giuseppe De Luca; Rosario Sauro; Attilio Varricchio; Michele Capasso; Tonino Lanzillo; Fiore Manganelli; Ciro Mariello; Francesco Siano; Maria Rosaria Pagliuca; Giovanni Stanco; Giuseppe Rosato
Journal: JACC Cardiovasc Interv Date: 2009-06 Impact factor: 11.195

8. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.

Authors: Stefan K James; Ulf Stenestrand; Johan Lindbäck; Jörg Carlsson; Fredrik Scherstén; Tage Nilsson; Lars Wallentin; Bo Lagerqvist
Journal: N Engl J Med Date: 2009-05-07 Impact factor: 91.245

9. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal: JAMA Date: 2002-07-17 Impact factor: 56.272

Review 10. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Authors: Adnan Kastrati; Alban Dibra; Christian Spaulding; Gerrit J Laarman; Maurizio Menichelli; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Melchior Seyfarth; Olivier Varenne; Maurits T Dirksen; Gianfranco Percoco; Attilio Varricchio; Undine Pittl; Mikko Syvänne; Maarten J Suttorp; Roberto Violini; Albert Schömig
Journal: Eur Heart J Date: 2007-09-27 Impact factor: 29.983

8 in total

The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data.

1. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

2. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

3. Statins and the risk of colorectal cancer.

4. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

5. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

6. Long-term follow-up of the West of Scotland Coronary Prevention Study.

7. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.

8. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.

9. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Review 10. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

1. Statement on matching language to the type of evidence used in describing outcomes data.

2. Statement on matching language to the type of evidence used in describing outcomes data.

3. Statement on matching language to the type of evidence used in describing outcomes data.

4. Statement on matching language to the type of evidence used in describing outcomes data.

5. Statement on matching language to the type of evidence used in describing outcomes data.

6. Response.

7. Attention to detail in the selection of words in epidemiologic research reports.

8. Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention.